A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Hyperthyroidism
Interventions
DRUG

Cyclotron-produced 99mTc

"Each research subject will serve as his/her own control, and will undergo imaging using both generator- and cyclotron-produced 99mTc. The study will follow the usual clinical procedure for routine imaging in the nuclear medicine department.~All subjects will be contacted by phone or in person the day following the injection of both generator and cyclotron-produced 99mTc to monitor for potential adverse events."

DRUG

Generator-produced 99mTc

"Each research subject will serve as his/her own control, and will undergo imaging using both generator- and cyclotron-produced 99mTc. The study will follow the usual clinical procedure for routine imaging in the nuclear medicine department.~All subjects will be contacted by phone or in person the day following the injection of both generator and cyclotron-produced 99mTc to monitor for potential adverse events."

Trial Locations (3)

V5Z 1M9

Vancouver General Hospital - Nuclear Medicine, Vancouver

L8N 4A6

Hamilton Health Sciences Centre, Hamilton

N6G 2V4

London Regional Health Sciences Centre, London

All Listed Sponsors
collaborator

Centre for Probe Development and Commercialization

OTHER

collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

collaborator

TRIUMF

UNKNOWN

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Natural Resources, Canada

UNKNOWN

lead

British Columbia Cancer Agency

OTHER

NCT02514187 - A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients | Biotech Hunter | Biotech Hunter